Inclusion Criteria:  Male, aged ≥18 years, with histologically confirmed adenocarcinoma of the prostate Has already undergone prostate MRI and/or scheduled to undergo clinically indicated radical prostatectomy (to permit whole-mount histopathology correlation). Intended treatment and follow-up according to standard of care for prostate cancer In good general health as evidenced by medical history and ECOG performance status 0-2 Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study  Exclusion Criteria:  Prior treatment for prostate cancer (cryotherapy, high frequency focused ultrasound, prostatectomy) Hip prosthesis Contraindication to MRI, per institutional requirements Patient has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator.